psychedelic medicine

Vancouver, Canada, July 16, 2026 Clearmind Medicine announced positive ex vivo results demonstrating enhanced nasal retention for its intranasal...

VANCOUVER, British Columbia, June 16, 2026 Optimi Health Corp. has announced the commercial production of two new standardized microdose...

TORONTO, Ontario, March 3, 2026 PharmAla Biotech Holdings Inc. has entered a supply and data agreement with Nautilus Sanctuary...